Filing Details

Accession Number:
0001562180-20-006920
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-25 16:38:59
Reporting Period:
2020-11-23
Accepted Time:
2020-11-25 16:38:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX Pharmaceutical Preparations (2834) 320162505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594274 Peter Ordentlich C/O Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-23 24,288 $3.08 24,288 No 4 M Direct
Common Stock Acquisiton 2020-11-23 5,684 $3.08 29,972 No 4 M Direct
Common Stock Disposition 2020-11-23 5,684 $23.33 24,288 No 4 S Direct
Common Stock Disposition 2020-11-23 7,954 $23.58 16,334 No 4 S Direct
Common Stock Disposition 2020-11-23 16,334 $22.89 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-11-23 24,288 $0.00 24,288 $3.08
Common Stock Stock Option (Right to Buy) Disposition 2020-11-23 5,684 $0.00 5,684 $3.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-09 No 4 M Direct
0 2023-05-09 No 4 M Direct
Footnotes
  1. The sales prices ranged from $22.94 to $23.73.
  2. The sales prices ranged from $23.35 to $23.94.
  3. The sales prices ranged from $22.34 to $23.32.
  4. This option is fully vested.